Humana Reports 40% Decrease In Q3 Earnings In Part Because Of Lower Medicare Drug Plan Revenues

Humana on Monday announced that third-quarter earnings decreased by 40% to $183 million, or $1.09 per share, from $302.4 million, or $1.78 per share, a year earlier, in large part because of investment losses and an expected decrease in premium revenue from Medicare prescription drug plans, the

More: continued here

Filed under: Health Insurance / Medical Insurance on October 29th, 2008